PENCICLOVIR (penciclovir) by Design Pharmaceuticals is dna polymerase inhibitors [moa]. Approved for recurrent herpes labialis (cold sores) in adults, older. First approved in 2023.
Drug data last refreshed 20h ago
DNA Polymerase Inhibitors
Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor
Non-inferiority Comparison of Efficacy and Safety of Penciclovir 10mg/g to Acyclovir 50mg/g in the Treatment of Recurrent Herpes Labialis
A Comparative Study of the Efficacy of Penciclovir 10mg/g (1%) Cream in Preventing the Appearance of Classical Lesion in Recurrent Cold Sore Sufferers
Worked on PENCICLOVIR at Design Pharmaceuticals? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.